In a brief YouTube segment, Speaker A cites a University of Pennsylvania study that reports a higher incidence of hair loss among users of GLP‑1 medications such as Ozempic, Wegovy, and Mounjaro compared with users of other diabetes drugs. Eric Roberts immediately challenges this interpretation, arguing that hair loss is not a direct pharmacological effect but rather a common consequence of rapid, aggressive calorie restriction that often accompanies GLP‑1‑induced weight loss. He explains that the body prioritizes essential functions over hair growth during a severe energy deficit, and that the observed association likely reflects faster weight loss rather than a drug‑specific side effect. Roberts advises viewers to avoid overly restrictive diets, suggesting a “healthy calorie deficit” tailored to the individual, and directs them to a link in his bio for personalized guidance.
